Neonatal HSV Infection: Classification, Risk Factors, and Urgent Management
Neonatal herpes simplex virus (HSV) infection is a medical emergency with high morbidity/mortality if untreated. Acquisition is primarily peripartum (vertical transmission).
Classification (Clinical Syndromes)
| Syndrome | Frequency | Features | Mortality (Untreated) |
| Skin, Eye, Mouth (SEM) | ~45% | Vesicles on skin, conjunctivitis, oral mucosa; no CNS/visceral involvement | ~0% |
| Central Nervous System (CNS) | ~30% | Seizures, lethargy, irritability, poor feeding, CSF pleocytosis; ± skin lesions | ~50% |
| Disseminated | ~25% | Multiorgan: hepatitis, pneumonitis, coagulopathy (DIC), encephalitis; ± skin lesions | ~85% |
Risk Factors for Transmission
- Maternal Primary HSV (1st/2nd trimester): ~30–50% transmission risk; highest if acquired in 3rd trimester (no maternal antibodies).
- Maternal Recurrent HSV: ~1–3% transmission; antibodies partially protective.
- Prematurity / Low Birth Weight: Immature skin/mucosal barrier, reduced IgG transfer.
- Prolonged Rupture of Membranes, Fetal Scalp Electrodes: Increase exposure.
Diagnosis
- PCR for HSV DNA: CSF (CNS), blood (disseminated), surface swabs (SEM).
- Viral culture (less sensitive).
- CSF: pleocytosis, elevated protein, normal/low glucose.
- LFTs, CBC, coagulation panel for disseminated disease.
Treatment (Start Empirically if High Suspicion)
- IV Acyclovir 20 mg/kg/dose q8h:
- SEM: 14 days
- CNS: 21 days
- Disseminated: 21 days
- Supportive: Seizure control, respiratory/circulatory support, nutrition.
- Repeat CSF PCR at end of CNS/disseminated course; extend if positive.
Prevention
- Suppressive acyclovir/valacyclovir from 36 weeks in women with recurrent HSV.
- Cesarean delivery if active lesions/prodrome at labor onset.
- Avoid fetal scalp electrodes if maternal HSV history.
Early IV acyclovir dramatically improves survival and neurodevelopmental outcomes. High index of suspicion is critical.
Baby Health - Related Articles